While Citi has maintained its 'buy' call for Cipla, it noted that a further delay in resolving issues at the Goa facility ...

Citi’s commentary comes as China-based pharma company Jiangsu Hengrui has received approval for Paclitaxel, the generic ...

The Nifty Pharma index has so far this year gained 54.42 percent while the benchmark Nifty advanced 26.94 percent in the same ...

Citi Maintains Buy On Cipla | Goa Unit Warning Letter Under Scanner#cipla #ciplastocks #brokerageradar #citi #businessnews ...

A media report said that the US Center for Medicare and Medicaid released a preliminary list of 101 generic drugs.

Discover the Cipla Stock Liveblog, your ultimate resource for real-time updates and insightful analysis on a prominent stock.

The Indian market is expected to consolidate on Thursday, influenced by mixed global cues. The Nifty futures experienced a ...

Stay up-to-date with the Cipla Stock Liveblog, your trusted source for real-time updates and thorough analysis of a prominent ...

Here's what Goldman Sachs, Jefferies, JPMorgan, Citi, Morgan Stanley, CLSA, and Nomura make of stocks such as Bandhan Bank, ...

UBS highlights growth opportunities for Sun Pharma and Cipla while raising alarms about profitability pressures in the Indian ...

One such company to wither the current storm that has hit some pharma companies is Cipla. The Mumbai-based pharma company saw its shares rise by over 2 per cent in the day's trade. Recently ...

Cipla (EU) Limited, UK a wholly owned subsidiary of Cipla Limited (BSE:500087; NSE: Cipla EQ], hereinafter referred to as Cipla has announced a strategic collaboration with Kemwell Biopharma ...